UCB Pharma SA: Clinical Trials

6 trials sponsored by UCB Pharma SA, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 16Completed 6

Follow UCB Pharma SA: new trials by email

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Certolizumab Pegol to Evaluate Pharmacokinetics and Safety in Adult Healthy Chinese Subjects
Certolizumab Pegol, Placebo - Healthy Subjects
Phase 1CompletedUCB Pharma SA362015-03-012015-08-14
Single-site, Open-label, Randomized, Cross-over Study in Healthy Chinese Subjects to Evaluate the Bioequivalence of Single-dose Rotigotine Transdermal Patch Comparing 2 Different Formulations
Rotigotine PR2.2.1, Rotigotine PR2.1.1 - Healthy
Phase 1CompletedUCB Pharma SA502014-02-012014-07-29
Bioavailability/Bioequivalence Study Between Lacosamide Tablet and Solution for Infusion in Healthy Japanese Subjects
Lacosamide infusion, Lacosamide oral - Healthy Volunteers
Phase 1CompletedUCB Pharma SA262013-11-012014-09-12
Comparison of Brivaracetam Oral Tablet (10 mg, 50 mg, 75 mg and 100 mg) and Brivaracetam Injection (100 mg) in Healthy Volunteers
Brivaracetam 10 mg oral tablet, Brivaracetam 50 mg oral tablet, Brivaracetam 75 mg oral tablet - Healthy Volunteers
Phase 1CompletedUCB Pharma SA252013-01-012013-04-15
A Study to Investigate the Drug-Drug Interactions of Brivaracetam and Ethanol in Healthy Male Subjects
Brivaracetam, Ethanol, Brivaracetam Placebo - Healthy Volunteers
Phase 1CompletedUCB Pharma SA182012-09-012018-10-11
Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes
Sodium Oxybate (Xyrem) - Narcolepsy With Cataplexy
Phase 1CompletedUCB Pharma SA252006-04-102022-04-08

Conditions studied

Narcolepsy (1)

Interventions

brivaracetam (2)  ·  Certolizumab Pegol (1)  ·  Ethanol (1)  ·  Lacosamide (1)  ·  Sodium Oxybate (1)  ·  Tablets (1)

Countries

China (2)  ·  Netherlands (2)  ·  Belgium (1)  ·  United Kingdom (1)

Results publications

PMID 30098648

NIH funding

2005 (1)